Transcatheter closure of patent foramen ovale in patients with migraine

Transcatheter closure of patent foramen ovale in patients with migraine - PFO closure in migraine patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000017216

Enrollment

Registered

2015-06-01

Start date

2015-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Migraine

Interventions

Amplatzer PFO Occluder

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with migraine headache and patent foramen ovale (PFO)

Exclusion criteria

Exclusion criteria: Patients without PFO Patients having contraindicated anticoagulation

Design outcomes

Primary

Measure	Time frame
Whether subjects with percutaneous PFO closure experience of migraine attacks.	—

Secondary

Measure	Time frame
Days, Degree, comorbidity related with migraine	—

Countries

Japan

Contacts

Public ContactTEIJI AKAGI

Okayama University Hospital Cardiac Intensive Care Unit

t-akagi@cc.okayama-u.ac.jp086-235-7357

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026